Protection against lethal leptospirosis after vaccination with LipL32 coupled or coadministered with the b subunit of escherichia coli heat-labile enterotoxin

Clinical and Vaccine Immunology

Volumn 19, Issue 5, 2012, Pages 740-745

  Grassmann, André A ^a   Félix, Samuel R ^a   Dos Santos, Carolina Ximendes ^a   Amaral, Marta G ^a   Neto, Amilton C P Seixas ^a   Fagundes, Michel Q ^a   Seixas, Fabiana K ^a   Da Silva, Éverton F ^a   Conceiçao, Fabricio R ^a   Dellagostin, Odir A ^a  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA SUBUNIT OF ESCHERICHIA COLI HEAT LABILE ENTEROTOXIN; ESCHERICHIA COLI ENTEROTOXIN; LEPTOSPIROSIS VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ESCHERICHIA COLI; FEMALE; INFECTION PREVENTION; LD 50; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; LETHALITY; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL TOXINS; BACTERIAL VACCINES; CRICETINAE; DISEASE MODELS, ANIMAL; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; FEMALE; LEPTOSPIRA INTERROGANS; LEPTOSPIROSIS; LIPOPROTEINS; SURVIVAL ANALYSIS; VACCINATION; VACCINES, SUBUNIT; VACCINES, SYNTHETIC;

EID: 84860340859     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05720-11     Document Type: Article

References (38)

1. Adler B, de la Pena Moctezuma A. 2010. Leptospira and leptospirosis. Vet. Microbiol. 140:287-296.
2. Atzingen MV, et al. 2010. Characterization of leptospiral proteins that afford partial protection in hamsters against lethal challenge with Leptospira interrogans. J. Med. Microbiol. 59:1005-1015.
3. Branger C, et al. 2001. Identification of the hemolysis-associated protein 1 as a cross-protective immunogen of Leptospira interrogans by adenovirus-mediated vaccination. Infect. Immun. 69:6831-6838. (Pubitemid 32995442)
4. Branger C, et al. 2005. Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysinassociated protein 1. Infect. Immun. 73:4062-4069. (Pubitemid 40923146)
5. Chang YF, et al. 2007. Immunogenicity of the recombinant leptospiral putative outer membrane proteins as vaccine candidates. Vaccine 25: 8190-8197.
6. Chen CG, et al. 2009. Amplification of immune responses against a DNA-delivered idiotypic lymphoma antigen by fusion to the B subunit of E. coli heat labile toxin. Vaccine 27:4289-4296.
7. Cullen PA, Cordwell SJ, Bulach DM, Haake DA, Adler B. 2002. Global analysis of outer membrane proteins from Leptospira interrogans serovar Lai. Infect. Immun. 70:2311-2318. (Pubitemid 34408370)
8. da Hora VP, Conceicao FR, Dellagostin OA, Doolan DL. 2011. Nontoxic derivatives of LT as potent adjuvants. Vaccine 29:1538-1544.
9. da Silva Ramos Rocha A, Conceicao FR, Grassmann AA, Lagranha VL, Dellagostin OA. 2008. B subunit of Escherichia coli heat-labile enterotoxin as adjuvant of humoral immune response in recombinant BCG vaccination. Can. J. Microbiol. 54:677-686.
10. Dellagostin OA, et al. 2011. Recombinant vaccines against leptospirosis. Hum. Vaccin. 7:1215-1224.
11. Felix SR, et al. 2009. Leptospirosis vaccine: Search for subunit candidates. Proc. Vaccinol. 1:110-114.
12. Felix SR, et al. 2011. Subunit approach to evaluation of the immune protective potential of leptospiral antigens. Clin. Vaccine Immunol. 18: 2026-2030.
13. Fernandes CP, et al. 2007. Monoclonal antibodies against LipL32, the major outer membrane protein of pathogenic Leptospira: Production, characterization, and testing in diagnostic applications. Hybridoma (Larchmt.) 26:35-41. (Pubitemid 46294372)
14. Fingerut E, Gutter B, Meir R, Eliahoo D, Pitcovski J. 2005. Vaccine and adjuvant activity of recombinant subunit B of E. coli enterotoxin produced in yeast. Vaccine 23:4685-4696. (Pubitemid 41132818)
15. Fingerut E, Gutter B, Goldway M, Eliahoo D, Pitcovski J. 2006. B subunit of E. coli enterotoxin as adjuvant and carrier in oral and skin vaccination. Vet. Immunol. Immunopathol. 112:253-263.
16. Fischer G, et al. 2007. Immunomodulation produced by a green propolis extract on humoral and cellular responses of mice immunized with SuHV-1. Vaccine 25:1250-1256. (Pubitemid 46039846)
17. Fraga TR, et al. 2010. Refolding of the recombinant protein OmpA70 from Leptospira interrogans from inclusion bodies using high hydrostatic pressure and partial characterization of its immunological properties. J. Biotechnol. 148:156-162.
18. Haake DA, et al. 2000. The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect. Immun. 68:2276-2285. (Pubitemid 30164865)
19. Haake DA, et al. 2004. Molecular evolution and mosaicism of leptospiral outer membrane proteins involves horizontal DNA transfer. J. Bacteriol. 186:2818-2828. (Pubitemid 38525937)
20. Habarta A, et al. 2011. Increased immunogenicity to LipL32 of Leptospira interrogans when expressed as a fusion protein with the cholera toxin B subunit. Curr. Microbiol. 62:526-531.
21. Hartwig DD, et al. 2010. High yield expression of leptospirosis vaccine candidates LigA and LipL32 in the methylotrophic yeast Pichia pastoris. Microb. Cell Fact. 9:98.
22. Hauk P, Guzzo CR, Roman Ramos H, Ho PL, Farah CS. 2009. Structure and calcium-binding activity of LipL32, the major surface antigen of pathogenic Leptospira sp. J. Mol. Biol. 390:722-736.
23. Hoke DE, Egan S, Cullen PA, Adler B. 2008. LipL32 is an extracellular matrix-interacting protein of Leptospira spp. and Pseudoalteromonas tunicata. Infect. Immun. 76:2063-2069. (Pubitemid 351656139)
24. Jagusztyn-Krynicka EK, Clark-Curtiss JE, Curtiss R III. 1993. Escherichia coli heat-labile toxin subunit B fusions with Streptococcus sobrinus antigens expressed by Salmonella typhimurium oral vaccine strains: Importance of the linker for antigenicity and biological activities of the hybrid proteins. Infect. Immun. 61:1004-1015. (Pubitemid 23059661)
25. Ko AI, Goarant C, Picardeau M. 2009. Leptospira: The dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat. Rev. Microbiol. 7:736-747.
26. Lucas DS, et al. 2011. Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model. Vaccine 29:3413-3418.
27. Malmstrom J, et al. 2009. Proteome-wide cellular protein concentrations of the human pathogen Leptospira interrogans. Nature 460:762-765.
28. Naiman BM, Alt D, Bolin CA, Zuerner R, Baldwin CL. 2001. Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes. Infect. Immun. 69:7550-7558. (Pubitemid 33086581)
29. Picardeau M, et al. 2008. Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis. PLoS One 3:e1607.
30. Seixas FK, et al. 2007. Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 26:88-95. (Pubitemid 350213201)
31. Seixas FK, et al. 2007. Evaluation of different ways of presenting LipL32 to the immune system with the aim of developing a recombinant vaccine against leptospirosis. Can. J. Microbiol. 53:472-479. (Pubitemid 47028512)
32. Silva EF, et al. 2007. The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 25:6277-6286. (Pubitemid 47088033)
33. Silva EF, et al. 2008. Characterization of virulence of Leptospira isolates in a hamster model. Vaccine 26:3892-3896.
34. Tucunduva de Faria M, et al. 2007. Morphological alterations in the kidney of rats with natural and experimental Leptospira infection. J. Comp. Pathol. 137:231-238.
35. Vernel-Pauillac F, Merien F. 2006. Proinflammatory and immunomodulatory cytokine mRNA time course profiles in hamsters infected with a virulent variant of Leptospira interrogans. Infect. Immun. 74: 4172-4179. (Pubitemid 43993351)
36. Vivian JP, et al. 2009. Crystal structure of LipL32, the most abundant surface protein of pathogenic Leptospira spp. J. Mol. Biol. 387:1229-1238.
37. Zhou WY, et al. 2009. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model. Vaccine 27: 5013-5019.
38. Zuerner RL, Alt DP, Palmer MV, Thacker TC, Olsen SC. 2011. A Leptospira borgpetersenii serovar Hardjo vaccine induces a Th1 response, activates NK cells, and reduces renal colonization. Clin. Vaccine Immunol. 18:684-691.